MICHELE YORK to Disease Progression
This is a "connection" page, showing publications MICHELE YORK has written about Disease Progression.
Connection Strength
0.340
-
Development of standardized regression-based formulas to assess meaningful cognitive change in early Parkinson's disease. Arch Clin Neuropsychol. 2021 Jul 19; 36(5):734-745.
Score: 0.085
-
Predictors of rate of cognitive decline in patients with amnestic mild cognitive impairment. Clin Neuropsychol. 2022 01; 36(1):138-164.
Score: 0.079
-
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease. Ann Clin Transl Neurol. 2020 04; 7(4):449-461.
Score: 0.078
-
A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler. 2010 Dec; 11(6):542-8.
Score: 0.039
-
Long-Term Dementia Risk in Parkinson Disease. Neurology. 2024 Sep 10; 103(5):e209699.
Score: 0.026
-
Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2015 Jun; 86(6):622-9.
Score: 0.013
-
Does apolipoprotein E genotype modify the clinical expression of ALS? Eur J Neurol. 2011 Apr; 18(4):618-24.
Score: 0.010
-
ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol. 2010 May; 17(5):733-9.
Score: 0.010